NDC 70954-504
Selegiline Hydrochloride
Selegiline Hydrochloride
Selegiline Hydrochloride is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Novitium Pharma Llc. The primary component is Selegiline Hydrochloride.
| Product ID | 70954-504_e42d99b0-c62e-49d4-b792-1301bb539b92 |
| NDC | 70954-504 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Selegiline Hydrochloride |
| Generic Name | Selegiline Hydrochloride |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-04-01 |
| Marketing Category | ANDA / |
| Application Number | ANDA075352 |
| Labeler Name | Novitium Pharma LLC |
| Substance Name | SELEGILINE HYDROCHLORIDE |
| Active Ingredient Strength | 5 mg/1 |
| Pharm Classes | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA],Monoamine Oxidase Type B Inhibitor [EPC],Monoamine Oxidase-B Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |